Overall rank by patents
#32,471
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, active 2021–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Murata holds 8 US patents across 8 technology areas, rank #32,471 of 50,000 tracked assignees.
Murata VIOS, Inc. has been granted 8 US utility patents between 2021 and 2023, placing Murata VIOS, Inc. at rank #32,471 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Murata VIOS, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Murata sits between MS Directional, Llc (8 patents, rank #32,467) and Mystery Ranch, Llc (8 patents, rank #32,475) - the closest US assignees by grant volume. The composite Innovation Score of 34.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2023, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Murata VIOS, Inc.'s 20.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Murata VIOS, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MS DIRECTIONAL, LLC
8 patents
MSD Consumer Care, Inc.
8 patents
MTEKVISION CO., LTD.
8 patents
MUELLER TEXTIL GMBH
8 patents
MUUTO A/S
8 patents
MYLAPS B.V.
8 patents
MYOTEST SA
8 patents
MYSTERY RANCH, LLC
8 patents
MURATA VIOS, INC.
8 patents
What this shows Murata holds 8 patents at rank #32,471, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,471 in granted patent volume.
Other assignees with the most granted patents in Murata's primary technology class.
Murata's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 54% higher than 46% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 5 | 62.5% |
| 2022 | 2 | 25.0% |
| 2023 | 1 | 12.5% |
Top 8 of 8 technology areas
Overall rank by patents
#32,471
Across all tracked assignees
34.0 out of 100
How to use this portfolio
Murata's 8 grants land it in the top 54% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.